In a fragmented EU market, the vaccines ecosystem is complex and in order for it to be “healthy” all relevant stakeholders should be taken into account, Professor Panos Kanavos, an associate professor at LSE, told EURACTIV.com.
Seven people have been diagnosed with measles in Zagreb in the past two weeks, raising concerns that more cases of this highly contagious virus may occur in light of the rising anti-vaccination campaigns.
There is no freedom of choice when it comes to vaccination because it involves putting other people’s health at risk, a top EU health official has warned, adding that ongoing debate in Italy about inoculations is verging "on the absurd".
The European Commission’s proposed recommendation on strengthened cooperation of all stakeholders against vaccine-preventable diseases should not remain a “piece of paper” as it needs to bring tangible results for all age groups, Commission officials told EURACTIV.com.
Multicomponent or combined vaccines are an indispensable tool to address the current public health challenges and Europe should, therefore, help unlock their potential, said Swedish MEP Christofer Fjellner.
If the scientific community sticks together and makes a coordinated effort, it can be very influential in shaping national vaccination plans, Italian professor Paolo Bonanni told EURACTIV.com, citing Italy as a prime example.
The European Commission could play a decisive role in further harmonising the regulatory framework of vaccines and therefore avoid delays in the supply of vaccines in case of shortages or emergencies, Vaccines Europe told EURACTIV.com.
Parents have a particular responsibility to protect their children, as they are more vulnerable to infections, but vaccination should be seen as a lifelong approach that applies to adults too, centre-right MEP Renate Sommer told EURACTIV.com.
The European Commission supports the creation of an electronic immunisation record system that will help EU member states enhance their cross-border cooperation and simultaneously enhance prevention of infectious diseases.
Over the next five years, international vaccine alliance GAVI hopes to immunise 300 million children against preventable diseases, with the German government pledging €600 million for the project. But NGOs warned that most of the money will end up pocketed by pharma giants. EURACTIV Germany reports.
SPECIAL REPORT: The Ebola crisis and immunisation campaigns in Africa have demonstrated the EU's added value in addressing global health issues. But there is still potential to improve if EU countries were less "suspicious" of each other, health experts say.
The Bundestag's 2015 budget plan includes a €1.8 million increase in funds for development cooperation. However, civil society organisations are criticising the sum as being marginal, calling for a considerably larger increase. EURACTIV Germany reports.
An estimated 1.5 million children will die from preventable diseases this year because they do not have access to vaccinations. At a June 25 workshop hosted by EURACTIV Germany, experts discussed current opportunities and challenges for health development in the world's poorest countries. EURACTIV.de reports
European Development Commissioner Andris Piebalgs has hailed the milestone passed by India on 13 January when it marked three years since its last reported polio case, the threshold for certifying a country free of the disease.
SPECIAL REPORT / Rising drug costs and supply uncertainty threaten efforts to achieve universal immunisation after decades of steady progress in vaccinating African infants against crippling and deadly diseases, health workers say.
The need for fast, accurate and balanced information is always important. We value EURACTIV's good, independent journalism and support this initiative
Mella Frewen, Director General of FoodDrinkEurope
EURACTIV plays a vital role in bringing Europe closer to its citizens. EURACTIV has long recognised that the story of Europe has to be told across the continent, and not just in Brussels. We need to support a truly European and informed debate.